U.S. drugmaker Pfizer is going "all in" to develop its experimental obesity drug and has been recruiting more experts in that ...

Obesity continues to grab attention at the J.P. Morgan Healthcare Conference in San Francisco, with both Pfizer and Kailera ...

Biopharma executives were busy Monday, striking high-value deals and providing updates on cancer, obesity and vaccine ...

The lawsuit alleges the price increases EpiPen, used to treat severe allergic reactions, prevented other similar medications ...

The global injectable potassium phosphate market is witnessing remarkable growth, with sales projected to rise from USD 562.6 ...

Pfizer has decided to discontinue the development ... which has been transformed in the last couple of years by injectable drugs working on GLP-1, such as Novo Nordisk’s Wegovy (semaglutide ...

Pfizer targets $4 billion in operational savings ... Above all, the obesity drug market is already crowded with established injectables and emerging orals. The efficacy, tolerability, and speed ...

Middle East and Asia Injectable Drugs market 2025 To achieve a therapeutic effect in humans and animals, drug delivery is the method of delivering a Pharmaceutical compound. Mr. Shah Coherent Market ...

Through the drug, Pfizer aims to offer patients a more convenient alternative to injectable drugs — Eli Lilly's Zepbound and Novo Nordisk's — that currently dominate the weight-loss treatment ...